Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $19.5 million.

  • Regenxbio's Prepaid Assets fell 1653.66% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 1653.66%. This contributed to the annual value of $13.8 million for FY2024, which is 3249.03% down from last year.
  • As of Q3 2025, Regenxbio's Prepaid Assets stood at $19.5 million, which was down 1653.66% from $19.5 million recorded in Q2 2025.
  • Regenxbio's Prepaid Assets' 5-year high stood at $27.3 million during Q1 2024, with a 5-year trough of $13.1 million in Q2 2021.
  • Its 5-year average for Prepaid Assets is $18.9 million, with a median of $18.8 million in 2021.
  • As far as peak fluctuations go, Regenxbio's Prepaid Assets surged by 8645.92% in 2021, and later tumbled by 4108.51% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Prepaid Assets stood at $18.8 million in 2021, then dropped by 25.87% to $13.9 million in 2022, then soared by 46.78% to $20.4 million in 2023, then tumbled by 32.49% to $13.8 million in 2024, then soared by 41.37% to $19.5 million in 2025.
  • Its last three reported values are $19.5 million in Q3 2025, $19.5 million for Q2 2025, and $16.1 million during Q1 2025.